Addiction and Deterrence@@@Anxiety Disorders@@@Mood Disorders@@@Psychopharmacology@@@Psychotherapy@@@Substance Abuse
Psychedelic compounds, while still highly regulated, are showing highly promising results in modern clinical trials. There are currently efforts to obtain pivotal efficacy data on these compounds in order to justify their rescheduling by the FDA. This session will provide an overview of the field of psilocybin assisted psychotherapy for psychiatric illness, including discussions of published and unpublished data from modern clinical trials for depression, anxiety, and substance use disorders. We will also provide an update on our open-label trial of psilocybin-assisted group therapy for demoralization in long-term AIDS survivors.